__NUXT_JSONP__("/drugs/PR1_Leukemia_Peptide_Vaccine", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"A cancer vaccine containing PR1, a 9 amino-acid human leukocyte antigen (HLA)-A2 restricted peptide derived from proteinase 3, with potential immunotherapeutic activity. Vaccination with PR1 leukemia peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing proteinase 3, resulting in tumor cell lysis. Often overexpressed in leukemic cells, proteinase 3 is a serine proteinase that activates progelatinase A and is involved in angiogenesis and metastasis.",fdaUniiCode:"54XUF2TZ7G",identifier:"C2235",preferredName:c,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C1752"],synonyms:["Leukemia Peptide Vaccine, PR1","PR1 LEUKEMIA PEPTIDE VACCINE",c,"Proteinase 3:PR1 Peptide"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FPR1_Leukemia_Peptide_Vaccine",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","PR1_Leukemia_Peptide_Vaccine","PR1 Leukemia Peptide Vaccine","2021-10-30T13:37:24.143Z")));